135 related articles for article (PubMed ID: 36115593)
21. One shoot, three birds: Targeting NEK2 orchestrates chemoradiotherapy, targeted therapy, and immunotherapy in cancer treatment.
Huang X; Zhang G; Tang T; Gao X; Liang T
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188696. PubMed ID: 35157980
[TBL] [Abstract][Full Text] [Related]
22. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.
Lu J; Hu Z; Deng Y; Wu Q; Wu M; Song H
J Biol Chem; 2021; 296():100400. PubMed ID: 33571521
[TBL] [Abstract][Full Text] [Related]
23. Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma.
McCrury M; Swafford K; Shuttleworth SL; Mehdi SH; Acharya B; Saha D; Naceanceno K; Byrum SD; Storey AJ; Xu YZ; Doshier C; Patel V; Post GR; De Loose A; Rodriguez A; Shultz LD; Zhan F; Yoon D; Frett B; Kendrick S
Mol Cancer Ther; 2024 Mar; 23(3):316-329. PubMed ID: 37816504
[TBL] [Abstract][Full Text] [Related]
24. Substrate specificity and cell cycle regulation of the Nek2 protein kinase, a potential human homolog of the mitotic regulator NIMA of Aspergillus nidulans.
Fry AM; Schultz SJ; Bartek J; Nigg EA
J Biol Chem; 1995 May; 270(21):12899-905. PubMed ID: 7759549
[TBL] [Abstract][Full Text] [Related]
25. The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression.
He C; Mao D; Hua G; Lv X; Chen X; Angeletti PC; Dong J; Remmenga SW; Rodabaugh KJ; Zhou J; Lambert PF; Yang P; Davis JS; Wang C
EMBO Mol Med; 2015 Nov; 7(11):1426-49. PubMed ID: 26417066
[TBL] [Abstract][Full Text] [Related]
26. Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo.
Xu CM; Liu WW; Liu CJ; Wen C; Lu HF; Wan FS
Cancer Gene Ther; 2013 Aug; 20(8):453-60. PubMed ID: 23928732
[TBL] [Abstract][Full Text] [Related]
27. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
[TBL] [Abstract][Full Text] [Related]
28. High expression of NEK2 promotes lung cancer progression and drug resistance and is regulated by mutant EGFR.
Chen C; Peng S; Li P; Ma L; Gan X
Mol Cell Biochem; 2020 Dec; 475(1-2):15-25. PubMed ID: 32761510
[TBL] [Abstract][Full Text] [Related]
29. High expression of NEK2 promotes gastric cancer progression via activating AKT signaling.
Wan H; Xu L; Zhang H; Wu F; Zeng W; Li T
J Physiol Biochem; 2021 Feb; 77(1):25-34. PubMed ID: 33201407
[TBL] [Abstract][Full Text] [Related]
30. microRNA-138 induces cell survival and reduces WNT/β-catenin signaling of osteoarthritis chondrocytes through NEK2.
Xu W; Gao P; Zhang Y; Piao L; Dong D
IUBMB Life; 2019 Sep; 71(9):1355-1366. PubMed ID: 31034758
[TBL] [Abstract][Full Text] [Related]
31. A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.
Lin C; Yao E; Chuang PT
Dev Biol; 2015 Jul; 403(1):101-13. PubMed ID: 25912685
[TBL] [Abstract][Full Text] [Related]
32. A novel interaction between kinase activities in regulation of cilia formation.
DeVaul N; Koloustroubis K; Wang R; Sperry AO
BMC Cell Biol; 2017 Nov; 18(1):33. PubMed ID: 29141582
[TBL] [Abstract][Full Text] [Related]
33. Human cytomegalovirus inhibits the proliferation and invasion of extravillous cytotrophoblasts via Hippo-YAP pathway.
Kong Q; Li J; Zhao L; Shi P; Liu X; Bian C; Liu J; Liu T
Virol J; 2021 Oct; 18(1):214. PubMed ID: 34717661
[TBL] [Abstract][Full Text] [Related]
34. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
35. The oncogenic kinase NEK2 regulates an RBFOX2-dependent pro-mesenchymal splicing program in triple-negative breast cancer cells.
Naro C; De Musso M; Delle Monache F; Panzeri V; de la Grange P; Sette C
J Exp Clin Cancer Res; 2021 Dec; 40(1):397. PubMed ID: 34930366
[TBL] [Abstract][Full Text] [Related]
36. The in vivo expression pattern of mouse Nek2, a NIMA-related kinase, indicates a role in both mitosis and meiosis.
Tanaka K; Parvinen M; Nigg EA
Exp Cell Res; 1997 Dec; 237(2):264-74. PubMed ID: 9434622
[TBL] [Abstract][Full Text] [Related]
37. Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1.
Fan R; Kim NG; Gumbiner BM
Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2569-74. PubMed ID: 23359693
[TBL] [Abstract][Full Text] [Related]
38. SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK.
Bae SJ; Ni L; Osinski A; Tomchick DR; Brautigam CA; Luo X
Elife; 2017 Oct; 6():. PubMed ID: 29063833
[TBL] [Abstract][Full Text] [Related]
39. MiR-1299 functions as a tumor suppressor to inhibit the proliferation and metastasis of prostate cancer by targeting NEK2.
Zhang FB; Du Y; Tian Y; Ji ZG; Yang PQ
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):530-538. PubMed ID: 30720160
[TBL] [Abstract][Full Text] [Related]
40. Effect of silencing NEK2 on biological behaviors of HepG2 in human hepatoma cells and MAPK signal pathway.
Zhang MX; Xu XM; Zhang P; Han NN; Deng JJ; Yu TT; Gan YY; He XQ; Long ZX
Tumour Biol; 2016 Feb; 37(2):2023-35. PubMed ID: 26337275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
